<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37648004</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2139</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Brain, behavior, and immunity</Title><ISOAbbreviation>Brain Behav Immun</ISOAbbreviation></Journal><ArticleTitle>Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men.</ArticleTitle><Pagination><StartPage>275</StartPage><EndPage>286</EndPage><MedlinePgn>275-286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2023.08.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-1591(23)00255-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sex-determined differences are rarely addressed in the management of diseases, despite well-known contrasting outcomes between female and male patients. In COVID-19 there is a remarkable disparity, with higher rates of mortality and more severe acute disease in men compared to women, who are mostly affected by long COVID-19. Furthermore, whether androgens play a protective or detrimental role in COVID-19 is still a matter of debate. Hence, the adequate management of the disease, especially regarding men presenting acute disease aggravation, still needs important data to elucidate the interplay between sex hormones and host immune responses that drive the worse evolution in male patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cohort of 92 controls and 198 non-severe and severe COVID-19 patients, from both sexes, was assessed for clinical outcomes, plasma steroids, gonadotropins, sex hormone binding globulin (SHBG) and immune mediators, before vaccination. These data were correlated with the global gene expression of blood leukocytes. The androgen receptor (AR) signaling pathway was investigated by transcriptomics and tracheal aspirate was obtained from severe patients for SARS-COV-2 quantification in the respiratory tract. The interplay among clinical, endocrine and immunological data deciphered the sex differences in COVID-19. Importantly, statistical analyses, using 95% confidence interval, considered confounding factors such as age and comorbidities, to definitely parse the role of androgens in the disease outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were notable contrasting levels of testosterone and dihydrotestosterone (DHT) throughout the disease course in male but not female patients. Inflammatory mediators presented significant negative correlations with testosterone, which was partially dependent on age and diabetes in men. Male subjects with severe COVID-19 had a significant up regulation of the AR signaling pathway, including modulation of TMPRSS2 and SRD5A1 genes, which are related to the viral infection and DHT production. Indeed, men had a higher viral load in the tracheal aspirate and levels of DHT were associated with increased relative risk of death. In contrast, the testosterone hormone, which was notably reduced in severe disease, was significantly related with susceptibility to COVID-19 worsening in male patients. Secondary hypogonadism was ruled out in the male severe COVID-19 subjects, as FSH, LH, and SHBG levels were not significantly altered. Instead, these subjects tended to have increased gonadotropin levels. Most interestingly, in this study we identified, for the first time, combined sets of clinical and immunoendocrine parameters that together predicted progression from non-severe to severe COVID-19 in men. One of the limitations of our study was the low or undetectable levels of DHT in many patients. Then, the evaluation of enzymes related to biosynthesis and signaling by androgens was mandatory and reiterated our findings.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These original results unraveled the disease immunoendocrine regulation, despite vaccination or comorbidities and pointed to the fundamental divergent role of the androgens testosterone and DHT in the determination of COVID-19 outcomes in men. Therefore, sex-specific management of the dysregulated responses, treatments or public health measures should be considered for the control of COVID-19 pandemic.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duarte-Silva</LastName><ForeName>Murillo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Camilla N S</ForeName><Initials>CNS</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuzo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Neto</LastName><ForeName>Pedro V</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Instituto de Ci&#xea;ncias Biol&#xf3;gicas Amazonas, Universidade Federal do Amazonas - UFAM, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toro</LastName><ForeName>Diana M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Instituto de Ci&#xea;ncias Biol&#xf3;gicas Amazonas, Universidade Federal do Amazonas - UFAM, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pimentel</LastName><ForeName>Vin&#xed;cius E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Malena M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraga-Silva</LastName><ForeName>Thais F C</ForeName><Initials>TFC</Initials><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Jonatan C S</ForeName><Initials>JCS</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Departamento de Qu&#xed;mica, Faculdade de Filosofia, Ci&#xea;ncias e Letras de Ribeir&#xe3;o Preto - FFCLRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Firmino M S</ForeName><Initials>FMS</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xfa;nior</LastName><ForeName>Ronaldo B M</ForeName><Initials>RBM</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil; Departamento de Biologia Celular e Molecular e Bioagentes Patog&#xea;nicos, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arruda</LastName><ForeName>Eurico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Biologia Celular e Molecular e Bioagentes Patog&#xea;nicos, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilar</LastName><ForeName>Fernando C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degiovani</LastName><ForeName>Augusto M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Hospital Santa Casa de Miseric&#xf3;rdia de Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostini</LastName><ForeName>F&#xe1;tima M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Hospital Santa Casa de Miseric&#xf3;rdia de Ribeir&#xe3;o Preto, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feitosa</LastName><ForeName>Marley R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parra</LastName><ForeName>Rogerio S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaspar</LastName><ForeName>Gilberto G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Jos&#xe9; J R</ForeName><Initials>JJR</Initials><AffiliationInfo><Affiliation>Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feres</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Ana P M</ForeName><Initials>APM</Initials><AffiliationInfo><Affiliation>Escola de Enfermagem de Ribeir&#xe3;o Preto, EERP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maruyama</LastName><ForeName>Sandra R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica e Evolu&#xe7;&#xe3;o, Centro de Ci&#xea;ncias Biol&#xf3;gicas e da Sa&#xfa;de, Universidade Federal de S&#xe3;o Carlos - UFSCar, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Elisa M S</ForeName><Initials>EMS</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonato</LastName><ForeName>V&#xe2;nia L D</ForeName><Initials>VLD</Initials><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Isabel K F M</ForeName><Initials>IKFM</Initials><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorgi</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Departamento de Bioqu&#xed;mica e Imunologia, Faculdade de Medicina de Ribeir&#xe3;o Preto - FMRP/USP, Brazil; Instituto de Ci&#xea;ncias Biol&#xf3;gicas Amazonas, Universidade Federal do Amazonas - UFAM, Brazil; Departamento de Qu&#xed;mica, Faculdade de Filosofia, Ci&#xea;ncias e Letras de Ribeir&#xe3;o Preto - FFCLRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias-Baruffi</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faccioli</LastName><ForeName>L&#xfa;cia H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Cristina R B</ForeName><Initials>CRB</Initials><AffiliationInfo><Affiliation>Departamento de An&#xe1;lises Cl&#xed;nicas, Toxicol&#xf3;gicas e Bromatol&#xf3;gicas, Faculdade de Ci&#xea;ncias Farmac&#xea;uticas de Ribeir&#xe3;o Preto - FCFRP/USP, Brazil. Electronic address: cristina@fcfrp.usp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ImmunoCOVID Brazilian Research Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Behav Immun</MedlineTA><NlmUniqueID>8800478</NlmUniqueID><ISSNLinking>0889-1591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Androgen receptor</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Dihydrotestosterone</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sexual dimorphism</Keyword><Keyword MajorTopicYN="N">Testosterone</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37648004</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2023.08.026</ArticleId><ArticleId IdType="pii">S0889-1591(23)00255-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>